Sanofi SA (ADR) news

   Watch this stock
Showing stories 1 - 10 of about 222   

Articles published

SNY 49.23 +1.15 (2.39%)
price chart
Google Inc Partners With Sanofi SA (ADR)
Google Inc. (NASDAQ:GOOG) announced that its healthcare research unit has entered into a collaboration with Sanofi SA ADR (NYSE:SNY).
Diabetes Is the First Target for Google Inc (GOOGL)'s Life Sciences  InvestCorrectly
The Stocks In News: Pharmacyte Biotech Inc (OTCMKTS:PMCB), Sanofi SA (ADR ...
Relypsa Inc (NASDAQ:RLYP) reported that it has finalized a two-year detailing deal with Sanofi SA (ADR)(NYSE:SNY) for Patiromer FOS.
Sanofi SA (ADR) Scouts For New Cancer Treatments That Harness Immune Cells
Pharmaceutical giant Sanofi is partnering with two biotech companies -- Evotec AG in Hamburg, Germany, and Apeiron Biologics AG in Vienna, Austria - in its latest effort to develop a drug that harnesses the body's own immune system in the fight against ...
Amgen, Inc. Or Sanofi SA (ADR) - Who Will Rule The Cholesterol Market?
Amgen, Inc. (NYSE:AMGN) and Sanofi SA ADR (NYSE:SNY) are all set to change the cholesterol drug market with their powerful new treatments that belong to a new class of drugs called PCSK9 protein inhibitors.
Sanofi SA (ADR) And Regeneron Pharmaceuticals Inc Down With Praluent's Limited ...
Sanofi SA (NYSE:SNY) and Regeneron Pharmaceuticals Inc. (NASDAQ:REGN) have received recommendation of approval for Praluent, their new drug.
FDA Panel Clears Product Path For Sanofi, Regeneron Pharmaceuticals  Benzinga
How Big of an Impact Could Praluent Have on Regeneron Pharmaceuticals Inc.?  Motley Fool
Sanofi SA (ADR) Chief Strategy Officer Resigns; Company Facing Another Turmoil ...
Sanofi SA (ADR) (NYSE:SNY), the French pharmaceutical giant, is facing another turmoil as its chief strategy officer, David-Alexandre Gros, has resigned only six months after the company's famous chief executive officer, Chris Viehbacher, was ousted by ...
Driven By Amgen, Inc. And Sanofi SA (ADR), US Drug Price War May Shift From ...
As per research presented at the annual meeting of the American College of Cardiology in March and conducted separately by Amgen, Inc. (NASDAQ:AMGN), and Sanofi SA (ADR) (NYSE:SNY) along with its development partner Regeneron Pharmaceuticals ...
Bayer's Brandicourt To Be Named Sanofi SA (ADR) CEO - Reports
Sanofi SA (ADR) (NYSE:SNY) has been searching for a candidate to replace its ousted Chief Executive Officer Chris Viehbacher ever since October last year; Olivier Brandicourt, head of Bayer AG (ADR)'s (OTCMKTS:BAYRY) healthcare business, might put ...
Sanofi SA (ADR) May Launch Toujeo In The US On Monday
Sanofi SA ADR (NYSE:SNY) plans to launch its new insulin, Toujeo, for the treatment of diabetic patients in the US as early as this Monday, people familiar with the matter said.
Dyax Corp. (DYAX) Takeover Talk: Shire PLC (ADR), Sanofi SA (ADR) Among ...
Dyax Corp. (NASDAQ:DYAX) was flagged as an attractive acquisition target by Bloomberg on Wednesday, on the back of its investigational drug that reported promising Phase 1b data at the annual meeting of the European Academy of Allergy and Clinical ...